Description
Oxanabol 10 mg British Dragon Pharmaceuticals
Product Description
Oxanabol 10 mg by British Dragon Pharmaceuticals is a high-quality anabolic steroid that contains Oxandrolone as its active ingredient. It is widely used by athletes and bodybuilders to enhance performance, promote muscle growth, and improve strength.
Specific Details
Oxanabol 10 mg is produced by British Dragon Pharmaceuticals, a reputable pharmaceutical company known for its commitment to quality and safety. Each tablet contains 10 mg of Oxandrolone, ensuring accurate dosing and consistent results.
Features and Benefits
• Promotes lean muscle growth and strength
• Enhances athletic performance
• Increases protein synthesis
• Reduces body fat
• Improves recovery time
• Does not convert to estrogen
• Suitable for both men and women
Possible Side Effects
While Oxanabol 10 mg is generally well-tolerated, some potential side effects may occur. These can include acne, oily skin, hair loss, and changes in libido. However, these side effects are rare and can be minimized with proper dosage and post-cycle therapy.
Usage and Dosage
For beginners, a typical dosage of Oxanabol 10 mg is 20-30 mg per day, divided into two equal doses. Experienced athletes may increase the dosage to 40-60 mg per day, depending on their goals and tolerance. The cycle duration is usually 6-8 weeks, followed by a post-cycle therapy to restore natural hormone production.
Benefits for the Buyer
By purchasing Oxanabol 10 mg from our online sports pharmacy, Anabolicsteroidsshop.com in England, customers can enjoy several benefits:
• Genuine and high-quality product from British Dragon Pharmaceuticals
• Accurate dosing and consistent results
• Discreet packaging and secure delivery
• Competitive prices and special offers
• Professional customer support and guidance
• Convenient and easy online ordering process
Choose Anabolicsteroidsshop.com as your trusted source for Oxanabol 10 mg and experience the benefits of this top-quality anabolic steroid.
Reviews
There are no reviews yet.